BNP Paribas Financial Markets’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-39,184
| Closed | -$2.06M | – | 4290 |
|
|
2020
Q3 | $2.06M | Buy |
39,184
+18,833
| +93% | +$780K | ﹤0.01% | 1499 |
|
|
2020
Q2 | $677K | Sell |
20,351
-40,188
| -66% | -$1.28M | ﹤0.01% | 1970 |
|
|
2020
Q1 | $1.65M | Buy |
60,539
+22,224
| +58% | +$619K | ﹤0.01% | 1604 |
|
|
2019
Q4 | $756K | Buy |
38,315
+7,395
| +24% | +$118K | ﹤0.01% | 2205 |
|
|
2019
Q3 | $401K | Buy |
30,920
+17,663
| +133% | +$213K | ﹤0.01% | 2336 |
|
|
2019
Q2 | $165K | Sell |
13,257
-8,759
| -40% | -$116K | ﹤0.01% | 2730 |
|
|
2019
Q1 | $320K | Buy |
22,016
+20,287
| +1,173% | +$259K | ﹤0.01% | 2397 |
|
|
2018
Q4 | $19.1K | Sell |
1,729
-2,593
| -60% | -$36.1K | ﹤0.01% | 3124 |
|
|
2018
Q3 | $114K | Buy |
4,322
+42
| +1% | +$1.14K | ﹤0.01% | 2673 |
|
|
2018
Q2 | $87.5K | Sell |
4,280
-20,151
| -82% | -$432K | ﹤0.01% | 2858 |
|
|
2018
Q1 | $443K | Sell |
24,431
-7,268
| -23% | -$121K | ﹤0.01% | 2298 |
|
|
2017
Q4 | $442K | Sell |
31,699
-7,793
| -20% | -$105K | ﹤0.01% | 2541 |
|
|
2017
Q3 | $731K | Buy |
39,492
+17,852
| +82% | +$298K | ﹤0.01% | 1763 |
|
|
2017
Q2 | $366K | Buy |
21,640
+8,247
| +62% | +$126K | ﹤0.01% | 2091 |
|
|
2017
Q1 | $179K | Buy |
13,393
+1,570
| +13% | +$24.6K | ﹤0.01% | 2266 |
|
|
2016
Q4 | $178K | Buy |
11,823
+2,071
| +21% | +$27.4K | ﹤0.01% | 2271 |
|
|
2016
Q3 | $114K | Sell |
9,752
-10,064
| -51% | -$118K | ﹤0.01% | 2037 |
|
|
2016
Q2 | $214K | Buy |
19,816
+10,617
| +115% | +$110K | ﹤0.01% | 1871 |
|
|
2016
Q1 | $85K | Sell |
9,199
-3,485
| -27% | -$37.5K | ﹤0.01% | 1841 |
|
|
2015
Q4 | $188K | Sell |
12,684
-4,858
| -28% | -$81.3K | ﹤0.01% | 1977 |
|
|
2015
Q3 | $288K | Buy |
17,542
+12,460
| +245% | +$255K | ﹤0.01% | 1719 |
|
|
2015
Q2 | $116K | Buy |
5,082
+3,945
| +347% | +$78.6K | ﹤0.01% | 2003 |
|
|
2015
Q1 | $17.3K | Buy |
+1,137
| New | +$14.8K | ﹤0.01% | 2437 |
|
|
2014
Q4 | – | Sell |
-2,856
| Closed | -$32.4K | – | 3533 |
|
|
2014
Q3 | $32.4K | Buy |
+2,856
| New | +$32.6K | ﹤0.01% | 2853 |
|
|
2014
Q1 | – | Sell |
-612
| Closed | -$10.8K | – | 3954 |
|
|
2013
Q4 | $10.8K | Sell |
612
-12,200
| -95% | -$205K | ﹤0.01% | 2597 |
|
|
2013
Q3 | $184K | Sell |
12,812
-3,331
| -21% | -$51K | ﹤0.01% | 2287 |
|
|
2013
Q2 | $243K | Buy |
+16,143
| New | +$213K | ﹤0.01% | 2172 |
|
BNP Paribas Financial Markets's MNTA Position: Q4 2020 in Review
BNP Paribas Financial Markets sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 39,184 shares — an estimated $2.06M sold.
BNP Paribas Financial Markets first reported a position in MNTA in Q2 2013 and held it in 27 quarters. The position peaked at $2.06M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- BNP Paribas Financial Markets reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- BNP Paribas Financial Markets sold 39,184 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $2.06M.
- BNP Paribas Financial Markets first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 27 quarters.
- BNP Paribas Financial Markets's Momenta Pharmaceuticals, Inc. position peaked at $2.06M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2020, filed 10 Feb 2021.